Cell lysis is vital step for study or research in proteomics, as protein can only be extracted if the cell lysis process is conducted. Furthermore, cell lysis is crucial step required to perform for nuclear extraction, after which the DNA is modified using the recombinant DNA technology.
The growing popularity of personalized medicines is one of the key factors driving the growth of this market in the next few years. The development of personalized medicine contributes to the exploration of new therapies for genetic anomalies. Genome mapping studies and the application of whole genome technology is extensively necessary to develop personalized medicines. The process of cell lysis is equally necessary to develop personalized medicine. Cell disruption is carried out to understand the interaction of cells. This helps researchers to develop or alter the structure of drugs to treat diseases. Additionally, the focus of the researchers to come up with new techniques such as reverse phase protein array (RPPA) technology for protein extraction to develop personalized medicine will also drive market growth since this technique involves homogenized cell lysis, which is performed using various methods.
Increasing cell-based research in North America due high demand for precision medicine is a major factor driving growth of the cell lysis market in this region. In 2015, the Precision Medicine Initiative was launched in the U.S. to revolutionize the treatment of diseases, which include cancer and other chronic diseases, as precision medicine offers tailored treatment for an individual according to genetic makeup of the person. The Asia Pacific region is also estimated to witness significant growth in cell lysis market, owing to increasing number of research laboratories and pharmaceutical companies with increased expenditure on research and development.
In 2018, the global Cell Lysis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cell Lysis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Lysis development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Market segment by Application, split into
Biopharmaceutical & Biotechnology Companies
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Cell Lysis status, future forecast, growth opportunity, key market and key players.
To present the Cell Lysis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cell Lysis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.